Homepage
Author:
Endogenex
Posted Date:
March 25, 2026
Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval
Endogenex
March 25, 2026
Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism
Endogenex
March 17, 2026
